



The Centers for Disease Control and Prevention (CDC) collects information from state and local health departments about 
each newly reported case of tuberculosis (TB) in the United States (U.S.). Reporting areas (i.e., the 50 states, the District of 
Columbia, several large U.S. cities, Puerto Rico, and other U.S.-affiliated jurisdictions in the Pacific and Caribbean) submit their 
information about TB cases to CDC’s National TB Surveillance System (NTSS) with a standard form, the Report of Verified Case 
of Tuberculosis (RVCT). The initial case report includes a patient’s demographic data, occupation, initial drug regimen, and 
information on HIV status, substance abuse, homelessness, and residence in correctional or long term-care facilities. Follow-up 
reports collect drug susceptibility test results for Mycobacterium tuberculosis isolates and treatment status, among other items.
CDC also collects information from reporting areas about their contact investigation activities: finding and examining persons 
who have had contact with TB cases, and treating those found to have TB disease or latent TB infection (LTBI). Data for contact 
investigation are reported by each TB control jurisdiction annually through the Aggregate Reports for Program Evaluation (ARPE).
National TB Indicators are key process and outcome measures for TB control programs in the United States. These indicators 
are selected by CDC in cooperation with partners in state and local health departments. Data for calculating these indicators 
are derived from existing surveillance systems such as NTSS and ARPE. CDC publishes TB indicator data to assist in evaluating 
progress toward achievement of national objectives through monitoring of TB program performance, assessment of needs for 
education and technical assistance, and identification of areas that need improvement.1,2
Incidence3
Elimination of TB is defined as reducing TB disease incidence  
in the United States to less than 1 case per million persons per  
year. Therefore, measuring the number of new cases occurring  
each year remains the best overall indicator of progress toward 
TB elimination. In 2015, TB incidence in the United States was  
3.0 overall TB cases (including U.S.-born and foreign-born  
persons) per 100,000 persons (30 per million). Overall, TB  
incidence has begun to level off over the past few years and  
the nation has not yet achieved the 2020 national target of  
≤1.4 cases per 100,000 (Figures 1 and 2).
1Data in this report are based on the final 2015 dataset from the National 
 TB Surveillance System (NTSS).
2For more information about the National TB Program Objectives and 
 Performance Targets for 2020 please visit http://www.cdc.gov/tb/programs/  
 evaluation/indicators/default.htm.
3Salinas J, Mindra G, Haddad M, Pratt R, Price S, Langer A. Leveling of 
 Tuberculosis Incidence—United States, 2013–2015. MMWR Morb Mortal  
 Wkly Rep. 2016;65(11):273–8.
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Figures 1 and 2. Overall TB Incidence*, United States, 2015
D.C.
Met 2020 target (≤1.4)*
Above 2020 target (1.4), but at or below national average (3.0)*
Above national average (>3.0)*
*Numbers of TB cases per 100,000 persons
In 2015, nine states and the District of Columbia reported 
incidences above the national average of 3.0 cases per 
100,000. Incidences in 41 states were at or below the 






















































*Numbers of TB cases per 100,000 persons. Data source: NTSS.
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Figures 3 and 4. TB Incidence*, US-born Persons, United States, 2015
l
D.C.
Met 2020 target (≤0.4)*
Above 2020 target (0.4), but at or below national average (1.2)*
Above national average (>1.2)*
*Numbers of TB cases per 100,000 U.S.-born persons
Alaska, 8.6
Hawaii, 3.9



















































*Numbers of TB cases per 100,000 U.S.-born persons. Data source: NTSS.
In 2015, a total of 11 states met the 2020 national target of 
0.4 cases per 100,000 U.S.-born persons; 23 states were 
short of the 2020 target, but reported incidences less than the 
national average of 1.2 cases per 100,000 U.S.-born persons. 
Note: To ensure better consistency with annual published TB incidences, U.S 
and foreign-born state incidences included in this report were calculated 
using the U.S. Census Bureau’s Current Population Survey. Therefore, U.S. and 
foreign-born state incidences presented in this report may differ from U.S. 
and foreign-born state incidences calculated using population data from other 
sources, such as the American Community Survey.
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Figures 5 and 6. TB Incidence*, Foreign-born Persons, United States, 2015
l
D.C.
Met 2020 target (≤11.1)*
Above 2020 target (11.1), but at or below national average (15.1)*
Above national average (>15.1)
























































In 2015, a total of 8 states met the 2020 national target of 
11.1 cases per 100,000 foreign-born persons; 20 states 
were short of the 2020 target, but still reported incidences 
of less than the national average of 15.1 cases per 100,000 
foreign-born persons.
*Numbers of TB cases per 100,000 foreign-born persons. Data source: NTSS.
Note: To ensure better consistency with annual published TB incidences, U.S 
and foreign-born state incidences included in this report were calculated 
using the U.S. Census Bureau’s Current Population Survey. Therefore, U.S. 
and foreign-born state incidences presented in this report may differ from 
U.S. and foreign-born state incidences calculated using population data from 
other sources, such as the American Community Survey.
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No reported TB cases among U.S.-born
non-Hispanic black persons 
Met 2020 target (≤1.5)*
Above 2020 target (1.5), but at or below national average (3.3)*
Above national average (>3.3)*







































*Numbers of TB cases per 100,000 U.S.-born non-Hispanic black persons. Data source: NTSS.
In 2015, a total of 6 states met the 2020 national target of 
1.5 cases per 100,000 U.S.-born non-Hispanic black persons; 
19 states were short of the 2020 target, but still reported 
incidences of less than the national average of 3.3 cases per 
100,000 U.S.-born non-Hispanic black persons. Fifteen states 
did not report any cases of TB among U.S.-born non-Hispanic 
black persons.
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For more information, see Reported Tuberculosis in the United States, 2015 at http://www.cdc.gov/tb/statistics/default.htm.  
If you need additional state-specific data not available in this report, you can contact your state TB control office at  
http://www.cdc.gov/tb/links/tboffices.htm.
Completion of Therapy 
Fully treating and, therefore, preventing further spread of Mycobacterium tuberculosis is key to TB control and elimination. If TB 
drugs are stopped too soon or not taken correctly, a person may become sick again or drug resistance may develop, enabling the 
further spread of TB. Each patient is unique, and there are many reasons why a patient might be unable or unwilling to complete 
TB treatment such as no longer experiencing symptoms of TB, not fully understanding the treatment regimen, not being willing 
or able to manage side effects of their treatment regimen, cultural beliefs, language barriers, difficulty getting health care, 
substance abuse, or mental health issues. Completion of therapy among persons who have experienced homelessness or 
been incarcerated can be particularly challenging due to difficulty locating patients for follow up care and treatment, and also 
particularly important because of the risk of transmission through shelter and jail or prison systems. There are several ways to 
increase treatment completion. These include directly observed therapy (in which patients are observed to ingest each dose of 
anti-TB medications) and use of incentives and enablers (e.g., giftcards for food or bus fare for transportation to get to and from 
the health department).
TB treatment is complex and can take several months to complete. It can take up to 2 years to have full treatment information 
reported for each TB patient. As a result, the most recent information available on completion of therapy is from 2013. For 
these patients, 12 states met or exceeded the 2020 national target of 95.0% of TB cases completing a full treatment regimen 
in 12 months or less; 16 states were short of the 2020 target, but exceeded the national average (89.6%) (Figure 9 on page 8). 
However, in 2013 there were 11 states that reported 9 or more TB patients, 15 years of age or older who were homeless; 6 of 
these states exceeded the national average of 85.2% completion of therapy among homeless TB patients (Table 1 on page 12).  
There were 8 states in 2013 that reported 5 or more TB patients, 15 years of age or older who were incarcerated; 4 of these 
states exceeded the national average of 79.8% completion of therapy among incarcerated TB patients (Table 2 on page 12).
HIV Status
People living with HIV are more likely than others to become sick with TB if they are exposed and infected. The risk of death 
from TB is also higher in HIV -infected persons. Untreated LBTI (see below) may quickly progress to TB disease in people living 
with HIV because the immune system is already weakened. Without treatment, TB disease can progress from sickness to death 
rapidly. Measuring the number of TB patients who are also tested for HIV and have a known HIV status is not only important in 
terms of saving lives, but also in interrupting the spread of TB and HIV to others.
In 2015, 24 states and the District of Columbia performed above the national average (88.5%) and 9 states met the 2020 
national target of having HIV status known among at least 98.0% of reported TB cases (Figure 10 on page 9).
Treatment for LTBI 
When a person with infectious TB coughs, droplet nuclei containing M. tuberculosis are expelled into the air. If another person 
inhales air containing these droplet nuclei, he or she may become infected. However, not everyone infected with TB bacteria 
develops symptoms of TB. As a result, two TB-related conditions exist: LTBI and TB disease. Persons with LTBI do not feel sick 
and do not have any symptoms. They are infected with M. tuberculosis, but do not have TB disease. The only sign of LTBI is a 
positive reaction to a TB skin test or TB blood test. Persons with LTBI are not infectious and cannot spread TB infection to others. 
However, at some point in their lives, 5–10% of all people with normal immune systems who have LTBI will become sick with 
TB disease. As previously described, the chances of progression from LTBI to TB disease are higher for persons with weakened 
immune systems, such as those infected with HIV. LTBI can be treated to prevent progression to TB disease. Thus, it is important, 
in terms of accelerating the decline in TB incidence, to measure how many people with LTBI begin and complete treatment. 
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TB programs work to identify persons who are 
at high risk for LTBI or at high risk for developing 
symptom of TB once infected so that they can be 
offered testing and treatment for LTBI. High-risk 
persons include known close contacts of someone 
with infectious TB disease, persons from regions 
of the world with high TB incidence, and those 
who work or reside in facilities or institutions 
with people who are also at high risk for TB. Risk 
factors for developing TB disease once infected 
include HIV infection, injection drug use, evidence 
of prior healed TB, diabetes, or low body weight. 
Infants and children under the age of five years are 
also at higher risk of getting sick with TB disease 
once infected.
In 2014, the most recent year for which data are 
available, 10 states met or exceeded the 2020 
national target of initiating treatment for 91.0% 
of people diagnosed with LTBI found during 
contact investigations; 26 states and the District 
of Columbia were short of the 2020 target, but 
exceeded  the national average (71.6%) (Figure 11 
on page 10).
In 2014, 20 states and the District of Columbia met 
or exceeded the 2020 national target of treatment 
completion for 81.0% of people diagnosed with 
LTBI through contact investigation and initiated 
treatment; 12 states were short of the 2020 target, 
but met or exceeded the national average of 
73.5% (Figure 12 on page 11).
For more information about TB disease and TB 
prevention and control activities in the United 
States, visit the National TB Controllers Association 
website at: http://www.tbcontrollers.org and the 
CDC TB website at: http://www.cdc.gov/tb.
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North Dakota, 75.0 (6/8)
New Hampshire, 83.3 (10/12)
South Dakota, 83.3 (5/6)
Ohio, 83.9 (99/118)
South Carolina, 84.8 (78/92)
Washington, 84.8 (151/178)





















New York, 93.7 (671/716)





















Note: DC, DE, IA, ID, KS, ME, MT, ND, NE, NH, NM, RI, SD, UT, VT, WI, WV, and WY reported 50 or fewer TB cases in 2013. Due to the small denominator, 
data should be interpreted with caution. The fraction in each parenthesis reports the number of TB patients who completed treatment within 12 
months out of the total number of patients who were eligible to complete treatment within 12 months. Data source: NTSS.
NATIONAL TB INDICATORS | 2015 STATE COMPARISON
Page 9 of 12
Figure 10: Percentage of TB Cases with Known HIV Status (Positive or Negative), 
United States, 2015
Massachusetts, 51.1 (97/190)
West Virginia, 75.0 (6/8)
South Dakota, 76.5 (13/17)
Wisconsin, 78.8 (52/66)
Alaska, 82.1 (55/67)
New Jersey, 82.3 (260/316)













Rhode Island, 89.7 (26/29)



















New Mexico, 97.6 (41/42)






North Dakota, 100.0 (9/9)








Note: DC, DE, IA, ID, KS, ME, MT, ND, NE, NH, NM, RI, SD, UT, VT, WI, WV, and WY reported 50 or fewer TB cases in 2013. Due to the small denominator, 
data should be interpreted with caution. The fraction in each parenthesis reports the number of TB patients with either positive or negative HIV test 
results out of the total number of TB patients. Data source: NTSS.
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Figure 11: Percentage of Contacts (to Sputum Acid-Fast Bacilli Smear-Positive  
TB Patients) Newly Diagnosed with LBTI Who Began Treatment, United States, 2014
Alaska, 28.3 (17/60)














Rhode Island, 75.9 (44/58)
Maryland, 76.4 (68/89)
North Carolina, 76.6 (271/354)
New Mexico, 77.8 (21/27)
Colorado, 78.9 (30/38)
South Carolina, 79.1 (68/86)
Florida, 79.6 (301/378)








New Jersey, 85.9 (164/191)
Maine, 85.9 (164/191)
Indiana, 87.2 (95/109)
New Hampshire, 87.5 (14/16)



















Note: MT and WY reported zero contacts diagnosed with TB infection. Data should be interpreted with caution because of the small denominator. 
The fraction in each parenthesis reports the number of contacts who started treatment out of those contacts newly diagnosed with TB infection. 
Data source: Aggregate Reports for Program Evaluation.
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Figure 12: Percentage of Contacts (to Sputum Acid-Fast Bacilli Smear-Positive TB Patients) 












West Virginia, 71.4 (5/7)























South Dakota, 88.9 (8/9)
South Carolina, 89.3 (25/28)
Colorado, 89.7 (61/68)






New Hampshire, 92.6 (315/340)
New Mexico, 92.9 (13/14)
Idaho, 95.2 (20/21)
Montana, 100.0 (2/2)





Note: MT and WY reported zero contacts diagnosed with TB infection. Data should be interpreted with caution because of the small denominator. 
The fraction in each parenthesis reports the number of contacts newly diagnosed with TB infection who completed treatment out of those contacts 
who started treatment. Data source: Aggregate Reports for Program Evaluation..
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Table 1. Treatment Completion within ≤12 Months among Newly Diagnosed TB Patients  
Age ≥15 Who were Homeless within the Year Prior to Diagnosis, United States, 2013
Statesa with 
1 to 3 TB














4 to 8 TB
patients age 














9 or more TB 
patients age 













Dist. of Columbia 100 85 Alaska 100 93 Indiana 100 96
Kansas 100 100 Alabama 100 96 North Carolina 100 98
Kentucky 100 91 Colorado 100 95 Florida 98 94
Massachusetts 100 92 Michigan 100 95 Georgia 92 89
Maryland 100 91 Tennessee 100 97 Arizona 89 86
Minnesota 100 94 Virginia 100 95 New York 87 94
Mississippi 100 90 Hawaii 80 90 Texas 83 88
North Dakota 100 75 Louisiana 75 74 California 81 89
New Hampshire 100 83 Pennsylvania 75 76 New Jersey 78 92
New Mexico 100 94 South Carolina 75 85 Illinois 73 90
Nevada 100 96 Washington 75 85 Arkansas 50 72








aCategorized based on lower third, middle third, and upper third numbers of cases reported among homeless persons age ≥15 who were eligible to complete treatment within 12 months;  
bAmong those age ≥15 who were eligible to complete treatment within 12 months; and Among all patients of any age who were eligible to complete treatment within 12 months. 
Note: DE, ID, MT, NE, RI, SD, VT, WV, WY did not report TB cases among persons age ≥15 experiencing homelessness who were eligible to complete treatment.
Table 2. Treatment Completion within ≥12 Months among Newly Diagnosed TB Patients 
Age ≥15 Who were Incarcerated at the Time of Diagnosis, United States, 2013
Statesa with
< 2 TB 
patients age 














2 to 4 TB 
patients age 









of all patients 
who completed 
treatment within 12 
monthsc
Statesa with
5 or more TB 
patients age 













Alaska 100 93 Illinois 100 90 New York 100 94
Colorado 100 95 Kentucky 100 91 Tennessee 100 97
Hawaii 100 90 Michigan 100 95 Arizona 85 86
Iowa 100 88 Oklahoma 100 93 North Carolina 80 98
Kansas 100 100 Oregon 100 87 California 79 89
New Hampshire 100 83 Arkansas 100 72 Texas 78 88
New Jersey 100 92 Mississippi 100 90 Florida 76 94
Nevada 100 96 Louisiana 75 74 Georgia 70 89
Wisconsin 100 90 South Carolina 75 85
Massachusetts 0 92 Pennsylvania 50 76
Washington 33 85
Missouri 0 75
aCategorized based on lower third, middle third, and upper third numbers of cases reported among incarcerated persons age ≥15 who were eligible to complete treatment within 
 12 months; bAmong those age ≥15 who were eligible to complete treatment within 12 months; and cAmong all patients of any age who were eligible to complete treatment within  
 12 months. Note: AL, CT, DC, DE, ID, IN, MD, ME, MN, MT, ND, NE, NM, OH, RI, SD, UT, VA, VT, WV, WY did not report TB cases among incarcerated persons age ≥15 who were eligible  
 to complete treatment.
